Foghorn Therapeutics (NASDAQ:FHTX) Receives Market Outperform Rating from JMP Securities
JMP Securities reissued their market outperform rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. They currently have a $9.00 target price on the stock. FHTX has been the topic of several other reports. Citizens Jmp started coverage on Foghorn Therapeutics in a report on […]
JMP Securities reissued their market outperform rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. They currently have a $9.00 target price on the stock. FHTX has been the topic of several other reports. Citizens Jmp started coverage on Foghorn Therapeutics in a report on […]
